Dataset | LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules |
Category | transcriptomics |
Type | small molecule perturbation |
Description | small molecule perturbation identified as [perturbation ID]_[perturbagen]_[cell line]_[time]_[time unit]_[dose]_[dose unit] (LINCS L1000 Connectivity Map) |
Similar Terms | |
Downloads & Tools |
60 genes differentially expressed following the BRD-K64857848_XMD-885_HEPG2_24_h_3.33_um small molecule perturbation from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
Symbol | Name |
---|---|
1060P11.3 | killer cell immunoglobulin-like receptor, three domains, pseudogene |
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) |
CLDN3 | claudin 3 |
CLU | clusterin |
CYR61 | cysteine-rich, angiogenic inducer, 61 |
EGR1 | early growth response 1 |
EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) |
FGF13 | fibroblast growth factor 13 |
HDAC9 | histone deacetylase 9 |
KRT5 | keratin 5, type II |
MECOM | MDS1 and EVI1 complex locus |
NMU | neuromedin U |
PAX8 | paired box 8 |
PCP4 | Purkinje cell protein 4 |
SLC3A1 | solute carrier family 3 (amino acid transporter heavy chain), member 1 |
SLPI | secretory leukocyte peptidase inhibitor |
TFPI2 | tissue factor pathway inhibitor 2 |
TRIM2 | tripartite motif containing 2 |
UCHL1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
USP22 | ubiquitin specific peptidase 22 |
Symbol | Name |
---|---|
ACTA1 | actin, alpha 1, skeletal muscle |
AEBP1 | AE binding protein 1 |
ARG1 | arginase 1 |
BCL2A1 | BCL2-related protein A1 |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 |
BGN | biglycan |
CACNA2D2 | calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 |
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) |
CHGB | chromogranin B |
CLC | Charcot-Leyden crystal galectin |
COCH | cochlin |
CXCL8 | chemokine (C-X-C motif) ligand 8 |
DLK1 | delta-like 1 homolog (Drosophila) |
ENOPH1 | enolase-phosphatase 1 |
EREG | epiregulin |
FABP5 | fatty acid binding protein 5 (psoriasis-associated) |
GATA3 | GATA binding protein 3 |
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 |
INHBA | inhibin, beta A |
LYPD3 | LY6/PLAUR domain containing 3 |
MAGEA12 | melanoma antigen family A12 |
MAGEA3 | melanoma antigen family A3 |
MAGEA6 | melanoma antigen family A6 |
NID1 | nidogen 1 |
NPTX2 | neuronal pentraxin II |
PCOLCE | procollagen C-endopeptidase enhancer |
PPAP2B | phosphatidic acid phosphatase type 2B |
PTPRN2 | protein tyrosine phosphatase, receptor type, N polypeptide 2 |
RBP1 | retinol binding protein 1, cellular |
S100A12 | S100 calcium binding protein A12 |
S100P | S100 calcium binding protein P |
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
SPON2 | spondin 2, extracellular matrix protein |
SQRDL | sulfide quinone reductase-like (yeast) |
TF | transferrin |
TM4SF1 | transmembrane 4 L six family member 1 |
TSPAN4 | tetraspanin 4 |
VCAN | versican |